JCM | Free Full-Text | Triple Negative Breast Cancer: An Analysis of the Subtypes and the Effects of Menopausal Status on Invasive Breast Cancer | HTML
Survival outcomes for dose‐dense paclitaxel plus carboplatin neoadjuvant vs standard adjuvant chemotherapy in stage II to III triple‐negative breast cancer: A prospective cohort study with propensity‐matched analysis - Xiu - 2022 -
Biomimetic black phosphorus quantum dots-based photothermal therapy combined with anti-PD-L1 treatment inhibits recurrence and metastasis in triple-negative breast cancer | Journal of Nanobiotechnology | Full Text
Frontiers | A Risk Stratification Model for Predicting Overall Survival and Surgical Benefit in Triple-Negative Breast Cancer Patients With de novo Distant Metastasis
Current Treatment Landscape and Emerging Therapies for Metastatic Triple-Negative Breast Cancer
Triple-negative breast cancer: treatment challenges and solutions | BCTT
Current Oncology | Free Full-Text | Current and New Novel Combination Treatments for Metastatic Triple-Negative Breast Cancer | HTML
Triple-negative breast cancer molecular subtyping and treatment progress
Genomic and Transcriptomic Landscape of Triple-Negative Breast Cancers: Subtypes and Treatment Strategies - ScienceDirect
Expression pattern and prognostic impact of glycoprotein non-metastatic B (GPNMB) in triple-negative breast cancer | Scientific Reports
Integrating Immunotherapy Into the Treatment Landscape for Patients With Triple-Negative Breast Cancer | American Society of Clinical Oncology Educational Book
Genetic Markers in Triple-Negative Breast Cancer - Clinical Breast Cancer
The feasibility of circulating tumor DNA analysis as a marker of recurrence in triple-negative breast cancer
![PDF] Triple-Negative Breast Cancer: Clinical Features and Patterns of Recurrence | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/623d56600e2bac528db05270048e03c7a6107aae/2-Table1-1.png "PDF] Triple-Negative Breast Cancer: Clinical Features and Patterns of Recurrence | Semantic Scholar")
PDF] Triple-Negative Breast Cancer: Clinical Features and Patterns of Recurrence | Semantic Scholar
Cureus | Clinical Behavior of Triple Negative Breast Cancer in a Cohort of Latin American Women
Circular RNA: A potential diagnostic, prognostic, and therapeutic biomarker for human triple-negative breast cancer: Molecular Therapy - Nucleic Acids
Integrated analysis reveals the molecular features of fibrosis in triple-negative breast cancer: Molecular Therapy - Oncolytics
A Predictor of Pathological Complete Response to Neoadjuvant Chemotherapy Stratifies Triple Negative Breast Cancer Patients with High Risk of Recurrence | Scientific Reports
Adjuvant capecitabine-containing chemotherapy benefit and homologous recombination deficiency in early-stage triple-negative breast cancer patients | British Journal of Cancer
Clinical significance of CD73 in triple-negative breast cancer: multiplex analysis of a phase III clinical trial - Annals of Oncology
Aurora-A Identifies Early Recurrence and Poor Prognosis and Promises a Potential Therapeutic Target in Triple Negative Breast Cancer | PLOS ONE
Prognosis of triple-negative breast cancer associated with pregnancy: A propensity score-matched analysis from the French CALG (Cancer Associé à la Grossesse) network - The Breast
How shall we treat early triple-negative breast cancer (TNBC): from the current standard to upcoming immuno-molecular strategies - ESMO Open
Locoregional recurrence of triple-negative breast cancer: effect of ty | BCTT
